The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI
Open accessAbstract
The science of toxicology is devoted, in large part, to understanding mechanisms of toxicity so that we can more accurately assess the risk posed by exposure to xenobiotic agents and, perhaps, intervene in the toxicologic process to mitigate harm. Dioxin-like chemicals continue to be of great concern as environmental toxicants. About 30 years ago the aryl hydrocarbon receptor (AHR) was discovered as a specific binding site for 2,3,7,8-tetrachlorodibenzo-p-dioxin. This giant step led to our current view that essentially all toxic effects of dioxins are AHR-mediated. The AHR serves as the archetype for understanding toxicity mediated by other soluble receptors. The fact that toxicity is receptor-mediated has important implications, especially for dose-response relationships. In laboratory animals genetic differences in AHR gene structure lead to profound differences in responsiveness to dioxin-like chemicals. Humans, however, exhibit relatively few AHR polymorphisms and these seem to exert only modest effects on downstream events. Dioxin toxicity is fundamentally due to AHR-mediated dysregulation of gene expression. Our current challenging goal is to determine which dysregulated genes underlie specific forms of dioxin toxicity. Mapping AHR-mediated gene expression in a variety of biological systems may help explain why dramatic differences in susceptibility to dioxin toxicity exist among laboratory species and why humans appear to be relatively resistant to adverse effects of dioxins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Van den Berg, M., Birnbaum, L. S., Denison, M., De Vito, M., Farland, W., Feeley, M., Fiedler, H., Hakansson, H., Hanberg, A., Haws, L., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl055 · Cited by 3,785
Herbst, A. L., Ulfelder, H., & Poskanzer, D. C. (1971) · New England Journal of Medicine · doi:10.1056/nejm197104222841604 · Cited by 2,520
Poland, A., & Knutson, J. C. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.002505 · Cited by 2,515
Denison, M. S., & Nagy, S. R. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135828 · Cited by 1,895 · cited 6×
“For example, arachidonic acid (AA) metabolites are released in response to TCDD and it is possible that some AA metabolites, such as prostaglandins, may act as AHR agonists (Denison and Nagy, 2003; Rifkind, 2006).”
BackgroundInfluentialSafe, S. (1990) · Critical Reviews in Toxicology · doi:10.3109/10408449009089873 · Cited by 1,871
Substrate-inducible Microsomal Aryl Hydroxylase in Mammalian Cell Culture
Nebert, D. W., & Gelboin, H. V. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94484-4 · Cited by 1,676
Poland, A., Glover, E., & Kende, A. S. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33205-2 · Cited by 1,370
Nebert, D. W., Dalton, T. P., Okey, A. B., & Gonzalez, F. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400004200 · Cited by 1,182
Self-citationINDUCTION OF CYTOCHROME P4501A1
Whitlock, J. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.103 · Cited by 1,124
Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1995) · Science · doi:10.1126/science.7732381 · Cited by 1,075
The PAS Superfamily: Sensors of Environmental and Developmental Signals
Gu, Y.-Z., Hogenesch, J. B., & Bradfield, C. A. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.519 · Cited by 1,029
Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., & Dalton, T. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00310-x · Cited by 1,004
Nebert, D. W., & Dalton, T. P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2015 · Cited by 958
Cloning of a Factor Required for Activity of the Ah (Dioxin) Receptor
Hoffman, E. C., Reyes, H., Chu, F.-F., Sander, F., Conley, L. H., Brooks, B. A., & Hankinson, O. (1991) · Science · doi:10.1126/science.1852076 · Cited by 957
Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., & Bradfield, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6731 · Cited by 891
Orphan Nuclear Receptors: From Gene to Function*
Giguère, V. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0378 · Cited by 855
Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.
Burbach, K. M., Poland, A., & Bradfield, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8185 · Cited by 831
Modulation of oestrogen receptor signalling by association with the activated dioxin receptor
Ohtake, F., Takeyama, K.-I., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., et al. (2003) · Nature · doi:10.1038/nature01606 · Cited by 798
Mammary Cancer Induced by a Single Feeding of Polynuclear Hydrocarbons, and its Suppression
HUGGINS, C., GRAND, L. C., & BRILLANTES, F. P. (1961) · Nature · doi:10.1038/189204a0 · Cited by 786
Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., & Simon, M. C. (1997) · Nature · doi:10.1038/386403a0 · Cited by 781
Reyes, H., Reisz-Porszasz, S., & Hankinson, O. (1992) · Science · doi:10.1126/science.256.5060.1193 · Cited by 777
Safe, S. H. (1986) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.26.040186.002103 · Cited by 710
Aryl hydrocarbon receptors: diversity and evolution
Hahn, M. E. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00070-4 · Cited by 642
Benzo[ a ]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor
Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., & Ishikawa, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.779 · Cited by 633
Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., et al. (1997) · Genes to Cells · doi:10.1046/j.1365-2443.1997.1490345.x · Cited by 626
Enzyme induction in the cytochrome P-450 system
Okey, A. B. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90030-6 · Cited by 625
Self-citationThe mammalian basic helix–loop–helix/PAS family of transcriptional regulators
Kewley, R. J., Whitelaw, M. L., & Chapman-Smith, A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00211-5 · Cited by 589
Schecter, A., Birnbaum, L., Ryan, J. J., & Constable, J. D. (2006) · Environmental Research · doi:10.1016/j.envres.2005.12.003 · Cited by 561
OEstrogenic Activity of Certain Synthetic Compounds
DODDS, E. C., GOLDBERG, L., LAWSON, W., & ROBINSON, R. (1938) · Nature · doi:10.1038/141247b0 · Cited by 514
Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. Y., Jabs, E. W., Li, X., Yin, H., Cody, C. W., & Greenlee, W. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36803-5 · Cited by 508
Orphan Nuclear Receptors: Shifting Endocrinology into Reverse
Kliewer, S. A., Lehmann, J. M., & Willson, T. M. (1999) · Science · doi:10.1126/science.284.5415.757 · Cited by 499
Gunton, J. E., Kulkarni, R. N., Yim, S., Okada, T., Hawthorne, W. J., Tseng, Y.-H., Roberson, R. S., Ricordi, C., O’Connell, P. J., Gonzalez, F. J., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.027 · Cited by 492
Ligand binding and activation of the Ah receptor
Denison, M. S., Pandini, A., Nagy, S. R., Baldwin, E. P., & Bonati, L. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00063-7 · Cited by 485 · cited 1×
“For example, several compounds of plant/dietary origin are potent AHR agonists in various in vitro assays but they do not mimic TCDD in regard to toxicity (Denison et al., 2002).”
BackgroundPohjanvirta, R., & Tuomisto, J. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06814-0 · Cited by 472
The Ah Locus: Genetic Differences in Toxicity, Cancer, Mutation, and Birth Defects
Nebert, D. W. (1989) · Critical Reviews in Toxicology · doi:10.3109/10408448909017908 · Cited by 453
Denison, M. S., Fisher, J. M., & Whitlock, J. P. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77819-3 · Cited by 451
Nebert, D. W., & Gelboin, H. V. (1969) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(69)90253-7 · Cited by 420
Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity
Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., & Gallo, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.510 · Cited by 405
cDNA cloning and structure of mouse putative Ah receptor
Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, O., Funae, Y., & Fujii-Kuriyama, Y. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91185-s · Cited by 403
Okey, A. B., Bondy, G. P., Mason, M. E., Kahl, G. F., Eisen, H. J., Guenthner, T. M., & Nebert, D. W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86532-8 · Cited by 399
Self-citation2,3,7,8,-Tetrachlorodibenzo-p-dioxin: segregation of toxocity with the Ah locus.
Poland, A., & Glover, E. A. (1980) · PubMed · Cited by 393
OKEY, A., RIDDICK, D., & HARPER, P. (1994) · Toxicology Letters · doi:10.1016/0378-4274(94)90139-2 · Cited by 380
Self-citationThe aryl hydrocarbon receptor: A comparative perspective
Hahn, M. E. (1998) · Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology · doi:10.1016/s0742-8413(98)10028-2 · Cited by 369
Herbst, A. L., Ulfelder, H., & Poskanzer, D. G. (1971) · Problems of Birth Defects · doi:10.1007/978-94-011-6621-8_32 · Cited by 358
Inhibitory Aryl Hydrocarbon Receptor−Estrogen Receptor α Cross-Talk and Mechanisms of Action
Safe, S., & Wormke, M. (2003) · Chemical Research in Toxicology · doi:10.1021/tx034036r · Cited by 348
Cloning and expression of a human Ah receptor cDNA.
Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., & Bradfield, C. A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13282-3 · Cited by 348
Aryl Hydrocarbon Receptor Regulates Distinct Dioxin-Dependent and Dioxin-Independent Gene Batteries
Tijet, N., Boutros, P. C., Moffat, I. D., Okey, A. B., Tuomisto, J., & Pohjanvirta, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.018705 · Cited by 341
Self-citationIdentification of Functional Domains of the Aryl Hydrocarbon Receptor
Fukunaga, B. N., Probst, M. R., Reisz-Porszasz, S., & Hankinson, O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29270 · Cited by 338
Targets for Dioxin: Genes for Plasminogen Activator Inhibitor-2 and Interleukin-1β
Sutter, T. R., Guzman, K., Dold, K. M., & Greenlee, W. F. (1991) · Science · doi:10.1126/science.1925598 · Cited by 337
Ah receptor: Dioxin-mediated toxic responses as hints to deregulated physiologic functions
Bock, K. W., & Köhle, C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.017 · Cited by 337
Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors.
Ema, M., Ohe, N., Suzuki, M., Mimura, J., Sogawa, K., Ikawa, S., & Fujii-Kuriyama, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46990-6 · Cited by 329
Genetic Expression of Aryl Hydrocarbon Hydroxylase Activity
Poland, A. P., Glover, E., Robinson, J. R., & Nebert, D. W. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79769-3 · Cited by 329
Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis
Marlowe, J. L., & Puga, A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20656 · Cited by 329
ARNT-Deficient Mice and Placental Differentiation
Kozak, K. R., Abbott, B., & Hankinson, O. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8758 · Cited by 328
Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor
Hankinson, O. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.031 · Cited by 327
Elucidating mechanisms of drug-induced toxicity
Liebler, D. C., & Guengerich, F. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1720 · Cited by 323
Dissecting the Functions of the Mammalian Clock Protein BMAL1 by Tissue-Specific Rescue in Mice
McDearmon, E. L., Patel, K. N., Ko, C. H., Walisser, J. A., Schook, A. C., Chong, J. L., Wilsbacher, L. D., Song, E. J., Hong, H.-K., Bradfield, C. A., et al. (2006) · Science · doi:10.1126/science.1132430 · Cited by 321
Analysis of the four alleles of the murine aryl hydrocarbon receptor
Poland, A., Palen, D., & Glover, E. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09833-5 · Cited by 303
Ma, Q., & Baldwin, K. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8432 · Cited by 302
The role of chaperone proteins in the aryl hydrocarbon receptor core complex
Petrulis, J. R., & Perdew, G. H. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00064-9 · Cited by 295
Genetic Mechanisms Controlling the Induction of Polysubstrate Monooxygenase (P-450) Activities
Nebert, D. W., Eisen, H. J., Negishi, M., Lang, M. A., Hjelmeland, L. M., & Okey, A. B. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.002243 · Cited by 295
Self-citationPOLAND, A., & GLOVER, E. (1974) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13874-1 · Cited by 295
Nuclear Localization and Export Signals of the Human Aryl Hydrocarbon Receptor
Ikuta, T., Eguchi, H., Tachibana, T., Yoneda, Y., & Kawajiri, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2895 · Cited by 287
Kim, S.-H., Henry, E. C., Kim, D.-K., Kim, Y.-H., Shin, K. J., Han, M. S., Lee, T. G., Kang, J.-K., Gasiewicz, T. A., Ryu, S. H., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021832 · Cited by 286
Estrogen receptor and aryl hydrocarbon receptor signaling pathways
Matthews, J., & Gustafsson, J.-Å. (2006) · Nuclear Receptor Signaling · doi:10.1621/nrs.04016 · Cited by 277
Substrate-inducible Microsomal Aryl Hydroxylase in Mammalian Cell Culture
Nebert, D. W., & Gelboin, H. V. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94485-6 · Cited by 264
A ligand for the aryl hydrocarbon receptor isolated from lung
Song, J., Clagett-Dame, M., Peterson, R. E., Hahn, M. E., Westler, W. M., Sicinski, R. R., & DeLuca, H. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232562899 · Cited by 264
Denison, M. S., Fisher, J. M., & Whitlock, J. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2528 · Cited by 260
Bandiera, S., Safe, S., & Okey, A. B. (1982) · Chemico-Biological Interactions · doi:10.1016/0009-2797(82)90045-x · Cited by 258
Self-citationIntrinsic Function of the Aryl Hydrocarbon (Dioxin) Receptor as a Key Factor in Female Reproduction
Baba, T., Mimura, J., Nakamura, N., Harada, N., Yamamoto, M., Morohashi, K.-I., & Fujii-Kuriyama, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10040-10051.2005 · Cited by 256
Pollenz, R. S. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00065-0 · Cited by 253
Sinal, C. J., & Bend, J. R. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.4.590 · Cited by 253
Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse
Nebert, D. W., Robinson, J. R., Niwa, A., Kumari, K., & Poland, A. P. (1975) · Journal of Cellular Physiology · doi:10.1002/jcp.1040850407 · Cited by 247 · cited 1×
“Breeding studies in mice supported this hypothesis (Nebert et al., 1975; Poland and Glover, 1975), setting the stage for use of radiolabeled TCDD in the search for the induction receptor.”
BackgroundEstrogenic Activity of o , p ′-DDT in the Mammalian Uterus and Avian Oviduct
Bitman, J., Cecil, H. C., Harris, S. J., & Fries, G. F. (1968) · Science · doi:10.1126/science.162.3851.371 · Cited by 243
POLAND, A., & GLOVER, E. (1975) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10636-6 · Cited by 243
Pharmacogenetics. Heredity and the Response to Drugs.
(1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-58-4-757 · Cited by 242
Molecular biology of the aromatic hydrocarbon (dioxin) receptor
Okey, A. B., Riddick, D. S., & Harper, P. A. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90316-6 · Cited by 236
Self-citationWalisser, J. A., Glover, E., Pande, K., Liss, A. L., & Bradfield, C. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504757102 · Cited by 234
Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor (AhR)-null mice
Peters, J. M., Narotsky, M. G., Elizondo, G., Fernandez-Salguero, P. M., Gonzalez, F. J., & Abbott, B. D. (1999) · Toxicological Sciences · doi:10.1093/toxsci/47.1.86 · Cited by 232
Hu, W., Sorrentino, C., Denison, M. S., Kolaja, K., & Fielden, M. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032748 · Cited by 225
Okey, A. B., Bondy, G. P., Mason, M. E., Nebert, D. W., Forster-Gibson, C. J., Muncan, J., & Dufresne, M. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70307-x · Cited by 224
Self-citationPoland, A., & Glover, E. A. (1973) · PubMed · Cited by 219
The transcriptional signature of dioxin in human hepatoma HepG2 cells
Puga, A., Maier, A., & Medvedovic, M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00403-2 · Cited by 217
Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., & Bradfield, C. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209594200 · Cited by 215
Savas, U., Bhattacharyya, K. K., Christou, M., Alexander, D. L., & Jefcoate, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36551-1 · Cited by 210
Matthews, J., Wihlén, B., Thomsen, J., & Gustafsson, J.-Å. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5317-5328.2005 · Cited by 210
Karchner, S. I., Franks, D. G., Kennedy, S. W., & Hahn, M. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509950103 · Cited by 207
Boverhof, D. R., Burgoon, L. D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J. R., Mendrick, D. L., & Zacharewski, T. R. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl100 · Cited by 206
Hazard and risk assessment of chemical mixtures using the toxic equivalency factor approach.
Safe, S. H. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106s41051 · Cited by 205
Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences
Sun, Y. V., Boverhof, D. R., Burgoon, L. D., Fielden, M. R., & Zacharewski, T. R. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh782 · Cited by 204
Beischlag, T. V., & Perdew, G. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500090200 · Cited by 203
Miller, A. G., Israel, D., & Whitlock, J. P. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32693-0 · Cited by 198
Dioxin and cancer: a critical review
Cole, P., Trichopoulos, D., Pastides, H., Starr, T., & Mandel, J. S. (2003) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2003.08.002 · Cited by 195
Cigarette Smoking: Stimulatory Effect on Metabolism of 3,4-Benzpyrene by Enzymes in Human Placenta
Welch, R. M., Harrison, Y. E., Conney, A. H., Poppers, P. J., & Finster, M. (1968) · Science · doi:10.1126/science.160.3827.541 · Cited by 193
Role of the aryl hydrocarbon receptor in cell cycle regulation
Puga, A., Xia, Y., & Elferink, C. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00069-8 · Cited by 192 · cited 1×
“Most notably, when activated by TCDD, the AHR forms a complex with the retinoblastoma protein (RB) which inhibits transcription of E2F-dependent genes leading to subsequent arrest of the cell cycle (reviewed in Huang and Elferink, 2005; Marlowe and Puga, 2005; Puga et al., 2002).”
BackgroundFujisawa-Sehara, A., Yamane, M., & Fujii-Kuriyama, Y. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5859 · Cited by 188
Boverhof, D. R., Burgoon, L. D., Tashiro, C., Chittim, B., Harkema, J. R., Jump, D. B., & Zacharewski, T. R. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi162 · Cited by 188
Pohjanvirta, R., Wong, J. M. Y., Li, W., Harper, P. A., Tuomisto, J., & Okey, A. B. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.86 · Cited by 184
Self-citationSingle-step selection of clones of a mouse hepatoma line deficient in aryl hydrocarbon hydroxylase.
Hankinson, O. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.373 · Cited by 181
Hestermann, E. V., Stegeman, J. J., & Hahn, M. E. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.9026 · Cited by 177
Ah receptor and NF-κB interactions: mechanisms and physiological implications
Tian, Y., Rabson, A. B., & Gallo, M. A. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00068-6 · Cited by 176
DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation
Swanson, H. I. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00066-2 · Cited by 176
Greenlee, W. F., & Poland, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83589-5 · Cited by 174
Fletcher, N., Wahlström, D., Lundberg, R., Nilsson, C. B., Nilsson, K. C., Stockling, K., Hellmold, H., & Håkansson, H. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.003 · Cited by 173
Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women.
Nebert, D. W., Winker, J., & Gelboin, H. V. (1969) · PubMed · Cited by 169
Manchester, D., Gordon, S. K., Golas, C. L., Roberts, E. A., & Okey, A. B. (1987) · PubMed · Cited by 168
Self-citationPolymorphisms in the human AH receptor
Harper, P. A., Wong, J. M. Y., Lam, M. S. M., & Okey, A. B. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00071-6 · Cited by 168
Self-citationLahvis, G. P., Pyzalski, R. W., Glover, E., Pitot, H. C., McElwee, M. K., & Bradfield, C. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008888 · Cited by 168
Denison, M. S., Vella, L. M., & Okey, A. B. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35611-9 · Cited by 167
Self-citationGasiewicz, T. A., & Neal, R. A. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90212-3 · Cited by 165
Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse
Moriguchi, T., Motohashi, H., Hosoya, T., Nakajima, O., Takahashi, S., Ohsako, S., Aoki, Y., Nishimura, N., Tohyama, C., Fujii-Kuriyama, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037886100 · Cited by 164
Whitelaw, M. L., Gustafsson, J. A., & Poellinger, L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8343 · Cited by 161
Pandini, A., Denison, M. S., Song, Y., Soshilov, A. A., & Bonati, L. (2007) · Biochemistry · doi:10.1021/bi061460t · Cited by 160 · cited 2×
“Homology modeling of the AHR ligand-binding domain gives some insight into the means by which the AHR recognizes ligands (Pandini et al., 2007) and provides support for previous findings (Ema et al.”
BackgroundResultRegulating the regulator: Factors that control levels and activity of the aryl hydrocarbon receptor
Harper, P. A., Riddick, D. S., & Okey, A. B. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.007 · Cited by 159
Self-citationWhitelaw, M., Göttlicher, M., Gustafsson, J.-Å., & Poellinger, L. (1993) · EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06101.x · Cited by 157
Hahn, M. E., Poland, A., Glover, E., & Stegeman, J. J. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1160 · Cited by 156
Roberts, B. J., & Whitelaw, M. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36351 · Cited by 156
Legraverend, C., Hannah, R. R., Eisen, H. J., Owens, I. S., Nebert, D. W., & Hankinson, O. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)65155-9 · Cited by 155
Conney, A. H. (2003) · PubMed · Cited by 154
Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms
Smart, J., & Daly, A. K. (2000) · Pharmacogenetics · doi:10.1097/00008571-200002000-00003 · Cited by 154
Okey, A. B., Vella, L. M., & Harper, P. A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11526-5 · Cited by 154
Self-citationHahn, M. E., Karchner, S. I., Evans, B. R., Franks, D. G., Merson, R. R., & Lapseritis, J. M. (2006) · Journal of Experimental Zoology Part A: Comparative Experimental Biology · doi:10.1002/jez.a.323 · Cited by 153
ahr null alleles: distinctive or different?
Lahvis, G. P., & Bradfield, C. A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00134-8 · Cited by 152
The Aryl hydrocarbon receptor is activated by modified low-density lipoprotein
McMillan, B. J., & Bradfield, C. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607296104 · Cited by 151
Rankin, E. B., Higgins, D. F., Walisser, J. A., Johnson, R. S., Bradfield, C. A., & Haase, V. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3163-3172.2005 · Cited by 150
7-Ketocholesterol Is an Endogenous Modulator for the Arylhydrocarbon Receptor
Savouret, J., Antenos, M., Quesne, M., Xu, J., Milgröm, E., & Casper, R. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005988200 · Cited by 149
Brunnberg, S., Pettersson, K., Rydin, E., Matthews, J. B., Hanberg, A., & Pongratz, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1136688100 · Cited by 148
Pesticide-induced Enzyme Breakdown of Steroids in Birds
Peakall, D. B. (1967) · Nature · doi:10.1038/216505a0 · Cited by 145
Abdelrahim, M., Ariazi, E. A., Kim, K., Khan, S., Barhoumi, R., Burghardt, R. C., Liu, S., Hill, D. S., Finnell, R. H., Wlodarczyk, B. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3132 · Cited by 144
Panteleyev, A. A., & Bickers, D. R. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00476.x · Cited by 143
Safe, S. H. (1998) · Journal of Animal Science · doi:10.2527/1998.761134x · Cited by 142
2,3,7,8-Tetrachlorodibenzo-p-dioxin: A Potent Inducer of δ-Aminolevulinic Acid Synthetase
Poland, A., & Glover, E. A. (1973) · Science · doi:10.1126/science.179.4072.476 · Cited by 139
3,4,3′,4′-Tetrachloro Azoxybenzene and Azobenzene: Potent Inducers of Aryl Hydrocarbon Hydroxylase
Poland, A., Clover, E., Kende, A. S., DeCamp, M. R., & Giandomenico, C. M. (1976) · Science · doi:10.1126/science.136041 · Cited by 138
Dose-Additive Carcinogenicity of a Defined Mixture of “Dioxin-like Compounds”
Walker, N. J., Crockett, P. W., Nyska, A., Brix, A. E., Jokinen, M. P., Sells, D. M., Hailey, J. R., Easterling, M., Haseman, J. K., Yin, M., et al. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.7351 · Cited by 136
Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells
Li, W., Harper, P. A., Tang, B.-K., & Okey, A. B. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00208-1 · Cited by 135
Self-citationGasiewicz, T. A., & Rucci, G. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14997-3 · Cited by 135
Tuomisto, J. T., Viluksela, M., Pohjanvirta, R., & Tuomisto, J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8564 · Cited by 133
Development of a Refined Database of Mammalian Relative Potency Estimates for Dioxin-like Compounds
Haws, L. C., Su, S. H., Harris, M. A., DeVito, M. J., Walker, N. J., Farland, W. H., Finley, B. L., & Birnbaum, L. S. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi294 · Cited by 133
Henry, E. C., Kende, A. S., Rucci, G., Totleben, M. J., Willey, J. J., Dertinger, S. D., Pollenz, R. S., Jones, J. P., & Gasiewicz, T. A. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23034-0 · Cited by 132
Photoaffinity labeling of the Ah receptor.
Poland, A., Glover, E. A., Ebetino, F. H., & Kende, A. S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84570-2 · Cited by 131
Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development
Walisser, J. A., Bunger, M. K., Glover, E. A., & Bradfield, C. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404379101 · Cited by 130
Poland, A., & Glover, E. A. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09468-4 · Cited by 130
Cell Density Regulates Intracellular Localization of Aryl Hydrocarbon Receptor
Ikuta, T., Kobayashi, Y., & Kawajiri, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310492200 · Cited by 125
Lin, T., Ko, K., Moore, R. W., Buchanan, D. L., Cooke, P. S., & Peterson, R. E. (2001) · Journal of Toxicology and Environmental Health · doi:10.1080/152873901316981312 · Cited by 125
Reiner, E. J., Clement, R. E., Okey, A. B., & Märvin, C. H. (2006) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0479-1 · Cited by 124
Self-citationWyde, M. E., Bartolucci, E., Ueda, A., Zhang, H., Yan, B., Negishi, M., & Li, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.474 · Cited by 123
OKEY, A., FRANC, M., MOFFAT, I., TIJET, N., BOUTROS, P., KORKALAINEN, M., TUOMISTO, J., & POHJANVIRTA, R. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.028 · Cited by 122
Self-citationA role for the aryl hydrocarbon receptor in mammary gland tumorigenesis
Schlezinger, J. J., Liu, D., Farago, M., Seldin, D. C., Belguise, K., Sonenshein, G. E., & Sherr, D. H. (2006) · Biological Chemistry · doi:10.1515/bc.2006.145 · Cited by 122
Patent Ductus Venosus and Dioxin Resistance in Mice Harboring a Hypomorphic Arnt Allele
Walisser, J. A., Bunger, M. K., Glover, E. A., Harstad, E. B., & Bradfield, C. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400784200 · Cited by 121
Severe 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Intoxication: Clinical and Laboratory Effects
Geusau, A., Abraham, K., Geissler, K. H., Sator, M. O., Stingl, G., & Tschachler, E. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109865 · Cited by 121
Ramadoss, P., & Perdew, G. H. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.129 · Cited by 121
Schmidt, J. V., Carver, L. A., & Bradfield, C. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80668-1 · Cited by 120
Bock, K. W., & Köhle, C. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.004 · Cited by 119
PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides
Coumoul, X., Diry, M., & Barouki, R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01298-4 · Cited by 118
Henry, E. C., Bemis, J. C., Henry, O., Kende, A. S., & Gasiewicz, T. A. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.02.008 · Cited by 117
Guo, J., Sartor, M. A., Karyala, S. V., Medvedovic, M., Kann, S., Puga, A., Ryan, P., & Tomlinson, C. R. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.09.002 · Cited by 115
TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
Riddick, D. S., Lee, C., Bhathena, A., Timsit, Y., Cheng, P., Morgan, E. T., Prough, R. A., Ripp, S. L., Miller, K. K. M., Jahan, A., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.4.367 · Cited by 114
Connor, K. T., & Aylward, L. L. (2006) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/15287390500196487 · Cited by 113
Aspartate Aminotransferase Generates Proagonists of the Aryl Hydrocarbon Receptor
Bittinger, M. A., Nguyen, L. P., & Bradfield, C. A. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.550 · Cited by 112
Rowlands, J. C., McEwan, I. J., & Gustafsson, J.-Α. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09308-3 · Cited by 111
Giannone, J. V., Li, W., Probst, M. R., & Okey, A. B. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00493-0 · Cited by 111
Self-citationElferink, C. J., Gasiewicz, T. A., & Whitlock, J. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30561-6 · Cited by 108
Ikuta, T., Kobayashi, Y., & Kawajiri, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.076 · Cited by 106
Polymorphisms of human Ah receptor gene are not involved in lung cancer
Kawajiri, K., Watanabe, J. A., Eguchi, H., Nakachi, K., Kiyohara, C., & Hayashi, S. (1995) · Pharmacogenetics · doi:10.1097/00008571-199506000-00003 · Cited by 106
Sogawa, K., Numayama‐Tsuruta, K., Takahashi, T., Matsushita, N., Miura, C., Nikawa, J., Gotoh, O., Kikuchi, Y., & Fujii‐Kuriyama, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.090 · Cited by 104
Multiple Mechanisms Are Involved in Ah Receptor-Mediated Cell Cycle Arrest
Huang, G., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002410 · Cited by 104
Mason, M. E., & Okey, A. B. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb06518.x · Cited by 103
Self-citationRifkind, A. B. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600570107 · Cited by 103
Martinez, J. M. (2002) · Toxicological Sciences · doi:10.1093/toxsci/69.2.409 · Cited by 103
Definition of a Dioxin Receptor Mutant That Is a Constitutive Activator of Transcription
McGuire, J., Okamoto, K., Whitelaw, M. L., Tanaka, H., & Poellinger, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105607200 · Cited by 102 · cited 1×
“, it stimulates gene expression without any ligand (Kohle et al., 2002; McGuire et al., 2001).”
BackgroundSafe, S. H. (1997) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/(sici)1520-6866(1997)17:4/5<285::aid-tcm11>3.0.co;2-b · Cited by 102
Variation in the molecular mass of the Ah receptor among vertebrate species and strains of rats
Poland, A., & Glover, E. A. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90811-4 · Cited by 102
Safe, S. H., & McDougal, A. J. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.6.1123 · Cited by 101
Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting
Boutros, P. C., Moffat, I. D., Franc, M. A., Tijet, N., Tuomisto, J., Pohjanvirta, R., & Okey, A. B. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.177 · Cited by 101
Self-citationSafe, S. H., Bandiera, S. M., Sawyer, T. W., Zmudzka, B., Mason, G., Romkes, M., Denommé, M. A., Sparling, J., Okey, A. B., & Fujita, T. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.856121 · Cited by 96
Self-citationRiddick, D. S., Huang, Y., Harper, P. A., & Okey, A. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32689-3 · Cited by 95
Self-citationHamilton, J. W., Denison, M. S., & Bloom, S. E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.11.3372 · Cited by 95
Nebert, D. W., & Bausserman, L. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62620-1 · Cited by 94
Watanabe, T., Imoto, I., Kosugi, Y., Fukuda, Y., Mimura, J., Fujii, Y., Isaka, K., Takayama, M., Sato, A., & Inazawa, J. (2001) · Journal of Human Genetics · doi:10.1007/s100380170070 · Cited by 93
Induction of Drug-Metabolizing Enzymes: A Path to the Discovery of Multiple Cytochromes P450
Conney, A. H. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135754 · Cited by 93
Belous, A. R., Hachey, D. L., Dawling, S., Roodi, N., & Parl, F. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2133 · Cited by 92
Pollenz, R. S., Santostefano, M. J., Klett, E., Richardson, V. M., Necela, B., & Bimbaum, L. S. (1998) · Toxicological Sciences · doi:10.1006/toxs.1998.2439 · Cited by 91
Okey, A. B., & Vella, L. M. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb06834.x · Cited by 88
Self-citationThe aryl hydrocarbon receptor and light
Rannug, A., & Fritsche, E. (2006) · Biological Chemistry · doi:10.1515/bc.2006.143 · Cited by 88
Boverhof, D. R., Kwekel, J. C., Humes, D. G., Burgoon, L. D., & Zacharewski, T. R. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019638 · Cited by 88
Carcinogenic risks of dioxin: Mechanistic considerations
Schwarz, M., & Appel, K. E. (2005) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2005.05.008 · Cited by 86
Lorenzen, A., & Okey, A. B. (1990) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(90)90105-4 · Cited by 86
Self-citationFryer, B. H., & Simon, M. C. (2006) · Cell Cycle · doi:10.4161/cc.5.5.2497 · Cited by 85
Purification and N-terminal amino acid sequence of the Ah receptor from the C57BL/6J mouse.
Bradfield, C. A., Glover, E. A., & Poland, A. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10873-0 · Cited by 83
Harper, P. A., Prokipcak, R. D., Bush, L. E., Golas, C. L., & Okey, A. B. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90587-9 · Cited by 81
Self-citationSustained Aryl Hydrocarbon Receptor Activity Attenuates Liver Regeneration
Mitchell, K. A., Lockhart, C. A., Huang, G., & Elferink, C. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023465 · Cited by 80
Anttila, S. L., Tuominen, P., Hirvonen, A., Nurminen, M. M., Karjalainen, A., Hankinson, O., & Elovaara, E. (2001) · Pharmacogenetics · doi:10.1097/00008571-200108000-00005 · Cited by 80
Okey, A. B., Dubé, A. W., & Vella, L. M. (1984) · PubMed · Cited by 77
Self-citationSasaki, S., Kondo, T., Sata, F., Saijo, Y., Katoh, S., Nakajima, S., Ishizuka, M., Fujita, S., & Kishi, R. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal013 · Cited by 77
Poland, A., Glover, E., & Bradfield, C. A. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10876-6 · Cited by 76 · cited 1×
“These experiments indicate apparent molecular masses ranging from 95 kDa for the product of the mouse Ahr allele to 146 kDa in trout (Hahn et al., 1994; Landers et al., 1989; Poland and Glover, 1987, 1990; Poland et al., 1991; Prokipcak and Okey, 1990).”
BackgroundPhysiological implications of estrogen receptor modulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin
Umbreit, T. H., & Gallo, M. A. (1988) · Toxicology Letters · doi:10.1016/0378-4274(88)90097-5 · Cited by 76
Harper, P. A., Golas, C. L., & Okey, A. B. (1988) · PubMed · Cited by 75
Self-citation3',4'-Dimethoxyflavone as an Aryl Hydrocarbon Receptor Antagonist in Human Breast Cancer Cells
Lee, J., & Safe, S. (2000) · Toxicological Sciences · doi:10.1093/toxsci/58.2.235 · Cited by 75
Tsui, H. W., & Okey, A. B. (1981) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y81-143 · Cited by 74
Self-citationHuman Aryl Hydrocarbon Receptor Polymorphisms That Result in Loss of CYP1A1 Induction
Wong, J. M. Y., Okey, A. B., & Harper, P. A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5861 · Cited by 73
Self-citation
Cited by
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Rothhammer, V., & Quintana, F. J. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0125-8 · Cited by 1,197
Epigenetics and environmental chemicals
Baccarelli, A., & Bollati, V. (2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32832925cc · Cited by 932
The aryl hydrocarbon receptor: multitasking in the immune system
Stockinger, B., Meglio, P. D., Gialitakis, M., & Duarte, J. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120245 · Cited by 909
Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., & Zhao, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr218 · Cited by 748
Metadata
- Authors
- Okey, A. B.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-10
- Volume
- 98
- Issue
- 1
- Pages
- 5-38
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2017985956
- Cited by
- 258
- References
- 296
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.